Endoprosthesis market size to grow by USD 18.24B from 2022-27

The endoprosthesis market size is set to grow by USD 18.24 billion from 2022 to 2027. However, the growth momentum will progress at a CAGR of 11.55% during the forecast period, according to Technavio. The endoprosthesis market is fragmented, and the vendors are seeking strong partnerships with automotive, industrial, and commercial companies to compete in the market. Arthrex Inc., B.Braun SE, Becton Dickinson and Co., Blatchford Ltd., Boston Scientific Corp., Hanger Inc, Exactech Inc., Johnson and Johnson Services Inc., Limacorporate SpA, Medacta International SA, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., Ossur hf, Smith and Nephew plc, Stryker Corp., TIPSAN Tibbi Aletler San. ve Tic. A.S., Trulife, W. L. Gore and Associates Inc., Wright Medical Group NV, and Zimmer Biomet Holdings Inc. are some of the major market participants.

Key endoprosthesis market drivers
The increasing prevalence of orthopedic diseases and associated risk factors are major factors driving market growth. The prevalence of orthopedic diseases, including arthritis and rheumatoid arthritis, has been steadily increasing over the years. This rise in prevalence is a key factor contributing to the growing cases of orthopedic diseases. For example, according to CDC data, approximately 20% of the US population is at risk of developing knee arthritis during their lifetimes. Additionally, risk factors such as obesity, which are associated with knee osteoarthritis, are also on the rise, further driving the prevalence of this condition. These factors are expected to fuel the growth of the global endoprosthesis market during the forecast period.

Significant endoprosthesis market trends
The growing popularity of biodegradable joint implants is an emerging trend shaping the market growth. Biodegradable joint implants are made from biodegradable polymers like polyglycolic acid (PGA), polylactic acid (PLA), and poly-B-hydroxybutyrate (PHB), which gradually dissolve over time, promoting the healing and regeneration of joint tissues. These implants are widely used for treating metaphyseal and periarticular fractures of joints. One of the key advantages of biodegradable joint implants is that they facilitate bone regrowth and eliminate the need for revision surgery. An example of such an implant is RegJoint, the world’s first biodegradable small finger and toe joint implant made of polylactide copolymer. It is embedded into the joint capsule to promote the regrowth of injured joint tissues and alleviate pain caused by friction between bones in patients with osteoarthritis and rheumatoid arthritis. These trends are expected to persist and drive the growth of the global endoprosthesis market during the forecast period.

Major endoprosthesis market challenges
Complications associated with the use of endoprosthesis implants are a major challenge hindering market growth. The use of endoprosthesis implants can lead to various complications, including infection, implant breakage, stiffness, periprosthetic cyst formation, malignant lymphoma, pain, joint stiffness, and damage to blood vessels and connective tissues. Additionally, there are associated risks such as allergic reactions, osteolysis, deposition of metal debris, bone erosion, silicone synovitis, embolism, and fibrous ankyloses. These complications have led to a decrease in patient preference for these implants, which is expected to hinder the growth of the global endoprosthesis market during the forecast period. Technavio